CRAd-S-pk7 is another glioma-tropic oncolytic adenovirus that contains the tumor-specific survivin promoter (S) and a fiber protein polylysine modification (pk7), with potential antineoplastic activity [140, 141]. Here, BIRC5 is linked to central nervous system cancer.